B

BNH

North America, Illinois, United States, Ohio

Description

BNH Investment Group is an real estate investment Management focused on providing investment solutions for SFH in the US market.

Investor Profile

BNH has made 5 investments, with 0 in the past 12 months and 40% as lead.

Stage Focus

  • Series A (40%)
  • Series Unknown (40%)
  • Series B (20%)

Country Focus

  • United States (40%)
  • South Korea (40%)
  • China (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Medical
  • Biopharma
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BNH frequently co-invest with?

DC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
Vickers Venture Partners
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Smilegate Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Korea Omega Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Devsisters Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
POSCO Venture Capital
Asia, Kyongsang-bukto, South Korea, Pohang
Co-Investments: 1
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
LSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by BNH?

Speclipse

Seongnam, Kyonggi-do, South Korea

Speclipse is a laser-based medical diagnostic technology.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownAug 19, 2021
Amount Raised: $7,700,000
Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BAug 5, 2021
Amount Raised: $29,000,000
Cytovant

Shanghai, Shanghai, China

Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.

BiopharmaBiotechnologyTherapeutics
Series UnknownApr 3, 2020
Amount Raised: $23,500,000
Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series ANov 29, 2019
Amount Raised: $15,000,000
Medizen Humancare

Songpadong, Seoul-t'ukpyolsi, South Korea

disease risk analysis service using genetic chip or analysis kit and specific disease-related genome variation package .

BiotechnologyGeneticsHealth CareMedical
Series AJan 1, 2014
Amount Raised: $8,700,000